SCHEMBL712469

SCHEMBL712469

CCCC([O])Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6244854 0.79
SCHEMBL6238715 0.76
SCHEMBL6244125 0.74 LCK (0.56)
SCHEMBL8372038 0.74
SCHEMBL6241700 0.74 LCK (0.56)
SCHEMBL6240694 0.74 LCK (0.56)
SCHEMBL6241560 0.74 LCK (0.56)
SCHEMBL6240631 0.74 LCK (0.56)
SCHEMBL6241408 0.74
SCHEMBL1001541 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110938426-A Method for preparing AgI quantum dots through supermolecular polymer network limitation 西北师范大学 2020-03-31 CN claimed
CN-115672295-B Preparation and application of imine type column [5] arene modified silica gel chromatographic packing 中国科学院兰州化学物理研究所 2023-12-15 CN disclosed
CN-112778156-B Bishydrazide structure compound, preparation method and application thereof 中国科学院上海药物研究所 2023-03-14 CN disclosed
EP-3660023-B1 THIENOPYRIMIDINEDIONE COMPOUNDS AS ACC INHIBITORS AND USE THEREOF NANJING SANHOME PHARMACEUTICAL CO LTD (CN) 2023-03-08 EP disclosed
CN-115672295-A Preparation and application of imine column [5] arene modified silica gel chromatographic packing 中国科学院兰州化学物理研究所 2023-02-03 CN disclosed
EP-3752492-B1 FUNGICIDAL OXADIAZOLES BAYER AG (DE) 2022-12-21 EP disclosed
CN-115215847-A KRAS-SOS1 inhibitor, preparation method and application thereof 中国科学院上海药物研究所 2022-10-21 CN disclosed
CN-109305976-B Compounds as ACC inhibitors and uses thereof 南京圣和药业股份有限公司 2022-07-01 CN disclosed
CN-110959007-B Compounds as ACC inhibitors and uses thereof 南京圣和药业股份有限公司 2022-07-01 CN disclosed
EP-3986877-A1 HYDROXYISOXAZOLINES AND DERIVATIVES THEREOF Bayer Aktiengesellschaft (DE) 2022-04-27 EP disclosed
US-5273998-A Process for making an optically active 3,4-dihydro-3,4-epoxy-2H-1-benzopyran compound YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1993-12-28 US disclosed
US-5202336-A Lipoxygenase inhibitors BAYER AKTIENGESELLSCHAFT (DE) 1993-04-13 US disclosed
US-5177216-A DIASTEREOMERIC ESTER COMPOUND USEFUL AS AN INTERMEDIATE IN THE MAKING OF AN OPTICALLY ACTIVE 3,4-DIHYDRO-3,4-EPOXY-2H-1-BENZOPYRAN COMPOUND YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1993-01-05 US disclosed
US-5093340-A Lipoxygenase enzyme inhibitors, antithrombolytic agents BAYER AKTIENGESELLSCHAFT (DE) 1992-03-03 US disclosed
US-5070096-A ANTICOAGULANTS, LIPOXYGENASE INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 1991-12-03 US disclosed
EP-0456266-A1 Method for preparing optically active 3,4-dihydro-3,4-epoxy-2H-1-benzopyran compounds, intermediates therefor and uses thereof YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1991-11-13 EP disclosed
US-5006534-A Substituted ethers, thioethers and amines for use as lipoxygenase inhibitors BAYER AKTIENGESELLSCHAFT (DE) 1991-04-09 US disclosed
US-4952598-A CALCIUM ANTAGONISTS HOECHST AKTIENGESELLSCHAFT (DE) 1990-08-28 US disclosed
US-4882329-A CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1989-11-21 US disclosed
US-4771062-A ENZYME INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 1988-09-13 US disclosed